These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34492081)
1. Novel Drexlerviridae bacteriophage KMI8 with specific lytic activity against Klebsiella michiganensis and its biofilms. Ku H; Kabwe M; Chan HT; Stanton C; Petrovski S; Batinovic S; Tucci J PLoS One; 2021; 16(9):e0257102. PubMed ID: 34492081 [TBL] [Abstract][Full Text] [Related]
2. Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase. Hsu CR; Lin TL; Pan YJ; Hsieh PF; Wang JT PLoS One; 2013; 8(8):e70092. PubMed ID: 23936379 [TBL] [Abstract][Full Text] [Related]
3. Lytic bacteriophage vB_KmiS-Kmi2C disrupts biofilms formed by members of the Klebsiella oxytoca complex, and represents a novel virus family and genus. Newberry F; Shibu P; Smith-Zaitlik T; Eladawy M; McCartney AL; Hoyles L; Negus D J Appl Microbiol; 2023 Apr; 134(4):. PubMed ID: 37070958 [TBL] [Abstract][Full Text] [Related]
4. Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Pertics BZ; Cox A; Nyúl A; Szamek N; Kovács T; Schneider G Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33801047 [No Abstract] [Full Text] [Related]
5. Comparative genome analysis of novel Podoviruses lytic for hypermucoviscous Klebsiella pneumoniae of K1, K2, and K57 capsular types. Solovieva EV; Myakinina VP; Kislichkina AA; Krasilnikova VM; Verevkin VV; Mochalov VV; Lev AI; Fursova NK; Volozhantsev NV Virus Res; 2018 Jan; 243():10-18. PubMed ID: 28988127 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a Lytic Bacteriophage and Demonstration of Its Combined Lytic Effect with a K2 Depolymerase on the Hypervirulent Pertics BZ; Kovács T; Schneider G Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985241 [No Abstract] [Full Text] [Related]
7. Klebsiella Phage ΦK64-1 Encodes Multiple Depolymerases for Multiple Host Capsular Types. Pan YJ; Lin TL; Chen CC; Tsai YT; Cheng YH; Chen YY; Hsieh PF; Lin YT; Wang JT J Virol; 2017 Mar; 91(6):. PubMed ID: 28077636 [TBL] [Abstract][Full Text] [Related]
9. Protective and therapeutic application of the depolymerase derived from a novel KN1 genotype of Klebsiella pneumoniae bacteriophage in mice. Wang C; Li P; Niu W; Yuan X; Liu H; Huang Y; An X; Fan H; Zhangxiang L; Mi L; Zheng J; Liu Y; Tong Y; Mi Z; Bai C Res Microbiol; 2019; 170(3):156-164. PubMed ID: 30716390 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic Insights into the Capsule-Targeting Depolymerase from a Klebsiella pneumoniae Bacteriophage. Dunstan RA; Bamert RS; Belousoff MJ; Short FL; Barlow CK; Pickard DJ; Wilksch JJ; Schittenhelm RB; Strugnell RA; Dougan G; Lithgow T Microbiol Spectr; 2021 Sep; 9(1):e0102321. PubMed ID: 34431721 [TBL] [Abstract][Full Text] [Related]
11. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. Lin TL; Hsieh PF; Huang YT; Lee WC; Tsai YT; Su PA; Pan YJ; Hsu CR; Wu MC; Wang JT J Infect Dis; 2014 Dec; 210(11):1734-44. PubMed ID: 25001459 [TBL] [Abstract][Full Text] [Related]
12. Complete genome analysis of a Siphoviridae phage TSK1 showing biofilm removal potential against Klebsiella pneumoniae. Tabassum R; Shafique M; Khawaja KA; Alvi IA; Rehman Y; Sheik CS; Abbas Z; Rehman SU Sci Rep; 2018 Dec; 8(1):17904. PubMed ID: 30559386 [TBL] [Abstract][Full Text] [Related]
13. Characterization and Genomic Analysis of a Novel Drexlervirial Bacteriophage IME268 with Lytic Activity Against Nazir A; Qi C; Shi N; Gao X; Feng Q; Qing H; Li F; Tong Y Infect Drug Resist; 2022; 15():1533-1546. PubMed ID: 35414748 [TBL] [Abstract][Full Text] [Related]
14. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713 [No Abstract] [Full Text] [Related]
15. Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca. Brown TL; Petrovski S; Hoyle D; Chan HT; Lock P; Tucci J PLoS One; 2017; 12(8):e0183510. PubMed ID: 28817689 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca. Karumidze N; Kusradze Ia; Rigvava S; Goderdzishvili M; Rajakumar K; Alavidze Z Curr Microbiol; 2013 Mar; 66(3):251-8. PubMed ID: 23143289 [TBL] [Abstract][Full Text] [Related]
17. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Verma V; Harjai K; Chhibber S Biofouling; 2010 Aug; 26(6):729-37. PubMed ID: 20711894 [TBL] [Abstract][Full Text] [Related]
18. Whole-genome sequence of a novel lytic bacteriophage infecting Bekircan Eski D; Gencer D; Darcan C J Gen Virol; 2024 Jul; 105(7):. PubMed ID: 39007232 [No Abstract] [Full Text] [Related]
19. Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae. Park EA; Kim YT; Cho JH; Ryu S; Lee JH Arch Virol; 2017 Apr; 162(4):1129-1139. PubMed ID: 28028618 [TBL] [Abstract][Full Text] [Related]
20. Biological properties and genomics analysis of vB_KpnS_GH-K3, a Klebsiella phage with a putative depolymerase-like protein. Cai R; Wang Z; Wang G; Zhang H; Cheng M; Guo Z; Ji Y; Xi H; Wang X; Xue Y; Ur Rahman S; Sun C; Feng X; Lei L; Tong Y; Han W; Gu J Virus Genes; 2019 Oct; 55(5):696-706. PubMed ID: 31254238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]